Cardiovascular considerations in COVID19: a comprehensive review

F Keihanian, L Bigdelu - Therapeutics and Clinical Risk …, 2020 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID19) is spreading rapidly and there is now much
concern regarding different aspects of public health. Underlying disorders like …

[HTML][HTML] COVID-19 and preventive strategy

C Krittanawong, N Maitra, A Kumar, J Hahn… - American Journal of …, 2022 - ncbi.nlm.nih.gov
In December 2019, an unprecedented outbreak of the novel coronavirus disease 2019
(COVID-19), an infectious disease caused by the severe acute respiratory syndrome …

[HTML][HTML] Toward understanding the 2019 Coronavirus and its impact on the heart

RC Becker - Journal of Thrombosis and Thrombolysis, 2020 - Springer
The 2019 Coronavirus (CoV)(SARS-severe acute respiratory syndrome CoV-2)(SARS-CoV-
2) pandemic has gripped the world's population in profound and unprecedented ways …

Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management

MI Restrepo, J Marin-Corral… - … in Respiratory and …, 2023 - thieme-connect.com
The coronavirus disease 2019 (COVID-19) pandemic has caused a devastating impact on
morbidity and mortality around the world. Severe acute respiratory syndrome-coronavirus-2 …

[HTML][HTML] Anticipating the long-term cardiovascular effects of COVID-19

RC Becker - Journal of thrombosis and thrombolysis, 2020 - Springer
SARS-CoV2 infection can impact all organs structurally and functionally. Persisting
symptoms in patients recovering from coronavirus disease 2019 (COVID-19) are common …

[HTML][HTML] Pathogenic basis of thromboinflammation and endothelial injury in COVID-19: current findings and therapeutic implications

Y Higashikuni, W Liu, T Obana, M Sata - International Journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global pandemic with a great impact on social …

[HTML][HTML] Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement

H Amirfakhryan - Hellenic Journal of Cardiology, 2021 - Elsevier
Since the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has emerged
from China, the infection (novel corona virus disease-2019, COVID-19) has affected many …

COVID‐19 (SARS‐CoV‐2) infection and thrombotic conditions: A systematic review and meta‐analysis

PR Gabbai‐Armelin, AB de Oliveira… - European Journal of …, 2021 - Wiley Online Library
Background COVID‐19 is an infectious disease caused by SARS‐CoV‐2 associated with
haematological manifestations (thrombolytic events). Aims Considering the high prevalence …

Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease

DG Della Rocca, M Magnocavallo, C Lavalle… - Journal of Thrombosis …, 2021 - Springer
• Schistocytes are fragments of red blood cells which may be encountered in the peripheral
blood smear of patients suffering from a variety of microangiopathic diseases.• In the …

[HTML][HTML] Platelet activation and thrombosis in COVID-19

T Iba, H Wada, JH Levy - Seminars in Thrombosis and …, 2023 - thieme-connect.com
Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated
with COVID-19 has unique characteristics. Compared with bacterial sepsis, COVID-19 …